Drug of Abuse Solutions

In a today’s healthcare environment, 116 million Americans suffering from chronic pain present physicians with challenges on two fronts:

  • The challenge and liability of providing this patient population adequate pain control while minimizing their risk for addiction.
  • Managing an increased patient population in a highly regulated healthcare system that increases the burden on the physician practice while delivering diminishing returns due to decreased reimbursement.

A critical component to a successful treatment plan in patient medication monitoring and compliance therapy is a comprehensive urine drug of abuse screening and confirmation solution.

Screening & Confirmation: A Two-Part Process

A laboratory must conduct an initial test called a screening test, followed by a confirmatory test on the sample before the specimen can be reported as positive, or negative if deemed medically necessary.

The application of immunoassays as a preliminary test to screen for drugs of abuse allows samples to be tested for the presence of drug or drug metabolites in various sample types. Immunoassay tests are based on the antibody-antigen reaction, which provides a relatively fast and straightforward way of determining if drug metabolites are present in the sample.

If initial screening tests produce positive results, a secondary analysis on the sample is required to confirm the presence and concentration of the specific drugs and drug metabolites. A Liquid Chromatography Mass Spectrometry (LC-MS) analyzer features greater sensitivity compared with other technologies and has the ability to rapidly detect a variety of drugs in a single run.

Our Turnkey Solution                                                                                     

From sample collection to reporting, Clinitox Diagnostix offers a program tailored for your lab. We provide our customers with consulting services, training, instruments, consumables and IT integration to ensure cost-effective, accurate testing and efficient operations. Let us manage your project from planning through implementation and then maintain your program with the highest level of customer service.

Choose a link below to learn more.

  • LCMS Calibration Solutions & Standards

    Clinitox Diagnostix calibration solutions and standards offer a simplified workflow solution delivering rapid and accurate results for pain management compounds spanning multiple drug classes. Our pre-tested and laboratory validated materials come complete with certificate of analysis, as well as documentation to ensure full traceability and lot management. Ready-to-use liquid formulations Custom Calibrant Spiking Mixture (CCSM) and Quality Control Spiking Mixture (QCSM) are ready-to-use

  • MedTest 200 Ensemble

       

  • MedTest 480 Ensemble

  • MedTest 800 Ensemble

  • Triple Quadrupole LC/MS System

    Following preliminary screening of a sample, the Liquid Chromatography Mass Spectrometry (LC-MS) analyzer provides rapid, accurate confirmation of the presence and concentration of the specific drugs and drug metabolites.  The LC-MS features greater sensitivity compared with other technologies and has the ability to rapidly detect a variety of drugs in a single run.  

Clinitox Diagnostix

Subscribe to our newsletter

Want to be notified when our article is published? Enter your email address and name below to be the first to know.